MARS SHOT
LIVE

Serial Number

90683427

Owner

Audubon Health Group, LLC

Attorney

Robert Devin Ricci

First Use Date

Apr 28, 2021

Filing Date

Apr 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MARS SHOT Trademark

Serial Number: 90683427 • Registration: 6712252

MARS SHOT is a trademark filed by Audubon Health Group, LLC on April 30, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Audubon Health Group, LLC (5 trademarks)

Suite 200, V112
Houston, TX 77054

Entity Type: 16

Trademark Details

Filing Date

April 30, 2021

Registration Date

April 26, 2022

First Use Anywhere

April 28, 2021

First Use in Commerce

April 28, 2021

Published for Opposition

February 8, 2022

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting research and clinical trials in the field of oncology and cancer research for others; Providing a website featuring educational information in the field of clinical research; Medical and scientific research, namely, conducting clinical trials for others; Providing medical testing services and information in the field of cancer research and disease classification; technical research and consulting in the field of pharmaceutical studies; Pharmaceutical research services; Pharmaceutical research and development; testing of pharmaceuticals; Biotechnology research; Medical research; DNA analysis services for scientific research purposes; Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing research information in the nature of medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of cancer treatment for others in the nature of conducting clinical trials for others; Providing clinical trial information in the nature of research data pertaining to cancer; development and validation of clinical trials and tests, and certification being the testing, analysis and evaluation of the clinical trials and tests of others to determine conformity with certification standards; Design, research, development and testing services in the field of pharmaceuticals, biobanking, and cancer research; Preclinical research services in the field of biospecimens collections; Research in the field of artificial intelligence for medical and scientific research purposes

Filing History

CANCELLATION INSTITUTED NO. 999999
Jul 10, 2024 PETC
REGISTERED-PRINCIPAL REGISTER
Apr 26, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 19, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 6, 2022 PREV
ASSIGNED TO LIE
Jan 5, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 3, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 3, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 3, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 3, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 2, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2021 NWOS
NEW APPLICATION ENTERED
May 4, 2021 NWAP